Is PRVA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PRVA. It does not provide personalized investment advice.

PRVA (Privia Health Group, Inc. Common Stock) Stock Analysis - Financials

Privia Health Group, Inc. Common Stock (PRVA) is a publicly traded Healthcare sector company. As of October 4, 2026, PRVA trades at $20.30 with a market cap of $2.59B and a P/E ratio of 106.84. PRVA moved +1.40% today. Year to date, PRVA is -13.47%; over the trailing twelve months it is -17.01%. Its 52-week range spans $18.77 to $28.82. Analyst consensus is strong buy with an average price target of $31.80. Rallies surfaces PRVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are PRVA's key financials?

PRVA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PRVA recently traded at $20.30. Market cap is $2.59B. P/E ratio is 106.84. Revenue is $2.12B.

PRVA Key Metrics

Key financial metrics for PRVA
Metric	Value
Price	$20.30
Market Cap	$2.59B
P/E Ratio	106.84
EPS	$0.19
Dividend Yield	0.00%
52-Week High	$28.82
52-Week Low	$18.77
Volume	967.98K
Avg Volume	0
Revenue (TTM)	$2.12B
Net Income	$29.73M
Gross Margin	0.00%

PRVA Analyst Consensus

11 analysts cover PRVA: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $31.80.

Common questions about PRVA

What are PRVA's key financials?: PRVA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PRVA recently traded at $20.30. Market cap is $2.59B. P/E ratio is 106.84. Revenue is $2.12B.
Is PRVA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PRVA. It does not provide personalized investment advice.